Daniel Marini
Chief Operating Officer bij ROBEX RESOURCES INC.
Vermogen: - $ op 30-04-2024
Profiel
Daniel Marini is currently the Chief Executive Officer at EryPharm SAS and the Chief Operating Officer at Robex Resources, Inc. He previously held the position of Chief Executive Officer at Grande Côte Operations SA and Director, General Manager & Country Manager at Assala Energy UK Ltd.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ROBEX RESOURCES, INC.
-.--% | 21-09-2023 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Daniel Marini
| Bedrijven | Functie | Begin |
|---|---|---|
| ROBEX RESOURCES INC. | Chief Operating Officer | 21-09-2023 |
EryPharm SAS
 EryPharm SAS BiotechnologyHealth Technology Part of Safi Biotherapeutics, Inc., EryPharm SAS is a biotech startup based in Paris, France. EryPharm is focused on the development of cultured red blood cells (CRBCs) technology, which was pioneered by the team in 2002. The French company aims to confirm the product's non-toxicity through clinical trials in 2022, followed by trials in 2023 to confirm the benefits of CRBCs. The go-to-market authorization is expected in 2028 at the latest. EryPharm SAS was founded in 2016 by Prof. Luc Douay's team, a spin-off from Sorbonne University. The CEO is Daniel Marini. EryPharm was acquired by Safi Biotherapeutics, Inc. on January 05, 2024. | Chief Executive Officer | - |
Eerdere bekende functies van Daniel Marini
| Bedrijven | Functie | Einde |
|---|---|---|
Assala Energy UK Ltd.
 Assala Energy UK Ltd. MiscellaneousMiscellaneous Assala Energy UK Ltd. operates as a holding company that engages in oil exploration and production. It operates five fields and has four interests in four non-operated fields. The company is headquartered in London, the United Kingdom. | Director/Board Member | - |
| Grande Côte Operations SA | Chief Executive Officer | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ROBEX RESOURCES INC. | Non-Energy Minerals |
| Bedrijven in privébezit | 3 |
|---|---|
| Grande Côte Operations SA | |
Assala Energy UK Ltd.
Assala Energy UK Ltd. MiscellaneousMiscellaneous Assala Energy UK Ltd. operates as a holding company that engages in oil exploration and production. It operates five fields and has four interests in four non-operated fields. The company is headquartered in London, the United Kingdom. | Miscellaneous |
EryPharm SAS
EryPharm SAS BiotechnologyHealth Technology Part of Safi Biotherapeutics, Inc., EryPharm SAS is a biotech startup based in Paris, France. EryPharm is focused on the development of cultured red blood cells (CRBCs) technology, which was pioneered by the team in 2002. The French company aims to confirm the product's non-toxicity through clinical trials in 2022, followed by trials in 2023 to confirm the benefits of CRBCs. The go-to-market authorization is expected in 2028 at the latest. EryPharm SAS was founded in 2016 by Prof. Luc Douay's team, a spin-off from Sorbonne University. The CEO is Daniel Marini. EryPharm was acquired by Safi Biotherapeutics, Inc. on January 05, 2024. | Health Technology |
